Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 7, 2023
Rhea-AI Summary
Xtant Medical Holdings, a global medical technology company, announced that CEO Sean Browne will present at the Canaccord Musculoskeletal Conference on March 7, 2023, at 3:30 p.m. PT in Las Vegas. The event will be accessible via a live webcast on the company’s website.
A replay of the webcast will be available for approximately 90 days post-presentation. Xtant Medical focuses on surgical solutions for spinal disorders, designing and developing orthobiologics and spinal implant systems for complex spinal procedures.
Positive
- None.
Negative
- None.
News Market Reaction – XTNT
In the trading session that priced this news, XTNT gained 3.47%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELGRADE, Mont., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeletal Conference, to be held on Tuesday, March 7, 2023 at 3:30 p.m. Pacific Time in Las Vegas.
A live webcast of the presentation will be available on the Investors section of the Company’s website or through the conference site by using the link below:
Date: Tuesday, March 7, 2023
Time: 3:30 p.m. PT / 6:30 p.m. ET
Webcast: Click Here
A replay of the webcast will be available for approximately 90 days on the Company’s website at www.xtantmedical.com following the conclusion of the presentation.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Matt Steinberg
Lazar FINN Partners
Ph: 646-871-8481
Email: matt.steinberg@finnpartners.com
